Gastrointestinal issues: Many GLP-1 supplements contain high amounts of fiber or other compounds that, especially when introduced suddenly or in large doses, can cause gastrointestinal discomfort, such as bloating, gas, and digestive upset
Int J Mol Sci 25:1469
FDA Approves Oral Semaglutide as the First GLP-1 Pill for Weight Loss The FDAs recent approval of oral semaglutide marks a revolutionary milestone in obesity medicine, introducing the first daily pill to deliver the powerful weight loss results previously restricted to injectable therapies
The goal is metabolic restoration
These cells are positive for NSE, synaptophysin , and occasionally chromogranin
Boehncke S, Fichtlscherer S, Salgo R, Garbaraviciene J, Beschmann H, Diehl S,